Trial Condition(s):

Therapeutic Equivalency, Postmenopause, Hormone Replacement Therapy

Study to demonstrate bioequivalence after single oral administration of the two different Estradiol Valerate-containing preparations in postmenopausal women

Bayer Identifier:

91121

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below.

Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
36
Trial Dates
black-arrow
Phase
1
Could I receive a placebo?
No
Products
Estradiol Valerate (EV, DS00124)
Accepts Healthy Volunteers
N/A

Where to Participate

Locations
Status
LocationsStatus

Trial Design